| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:456701462:1787 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:456701462:1787?format=raw |
LEADER: 01787cam a2200409 a 4500
001 3912170
005 20221027000507.0
008 840731t19841984nyua b 100 0 eng
010 $a 84006985
035 $a(OCoLC)10727252
035 $a(OCoLC)ocm10727252
035 $a(CStRLIN)NYCM84-B1972
035 $9ADG4437HS
035 $a(NNC)3912170
035 $a3912170
040 $dCStRLIN$dNNC-M
050 10 $aRC685.H8$bL24 1984
060 0 $aWG 340 L117
082 0 $a616.1/32061$219
245 00 $aLabetalol plus chlorthalidone in a fixed combination (RG 136) :$ba rational approach to antihypertensive therapy /$ceditors, A. Zanchetti, M. Condorelli ; associate-editors, G. Mancia, F. Granata, G.P. Tornieri.
260 $aNew York, N.Y. :$bRaven Health Care Communications,$c[1984], ©1984.
300 $a78 pages :$billustrations ;$c28 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographies.
650 0 $aHypertension$xChemotherapy$vCongresses.
650 0 $aLabetalol$xTesting$vCongresses.
650 0 $aChlorthalidone$xTesting$vCongresses.
650 0 $aChemotherapy, Combination$xEvaluation$vCongresses.
650 2 $aChlorthalidone$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D002752Q000627
650 2 $aDrug Combinations.$0https://id.nlm.nih.gov/mesh/D004338
650 2 $aEthanolamines$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D004983Q000627
650 2 $aHypertension$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D006973Q000188
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aZanchetti, Alberto.$0http://id.loc.gov/authorities/names/n81013497
700 1 $aCondorelli, M.$0http://id.loc.gov/authorities/names/n77019223
852 00 $boff,hsl$hRC685.H8$iL11 1984